Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
287
1.710
Why?
Carcinoma, Squamous Cell
15
2010
326
1.630
Why?
DNA Methylation
13
2009
550
1.110
Why?
DNA Glycosylases
5
2011
19
1.040
Why?
Gene Silencing
7
2009
115
1.030
Why?
Promoter Regions, Genetic
11
2009
465
1.020
Why?
Mitochondria
3
2011
399
0.510
Why?
DNA Repair
5
2008
188
0.500
Why?
Adaptor Proteins, Signal Transducing
5
2009
198
0.470
Why?
Polymerase Chain Reaction
11
2009
449
0.470
Why?
Kidney Neoplasms
2
2008
174
0.460
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
154
0.460
Why?
DNA, Neoplasm
10
2008
143
0.450
Why?
Nuclear Proteins
5
2009
238
0.450
Why?
Neoplasm Proteins
4
2005
320
0.410
Why?
Laryngeal Neoplasms
3
2007
43
0.380
Why?
Vascular Endothelial Growth Factor A
2
2009
182
0.370
Why?
CpG Islands
3
2008
108
0.360
Why?
Lung Neoplasms
2
2007
601
0.340
Why?
Microsatellite Instability
1
2009
19
0.330
Why?
Fatty Liver
1
2011
130
0.330
Why?
Immunohistochemistry
7
2012
957
0.330
Why?
Mitochondrial Proteins
2
2007
88
0.320
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.310
Why?
Port-Wine Stain
1
2008
14
0.310
Why?
Oxygen
1
2011
321
0.300
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.290
Why?
Genes, p16
3
2005
8
0.290
Why?
Lymph Nodes
2
2007
257
0.290
Why?
Skin
3
2010
388
0.290
Why?
DNA, Mitochondrial
4
2011
111
0.280
Why?
N-Glycosyl Hydrolases
1
2007
6
0.280
Why?
Carcinoma, Renal Cell
1
2008
101
0.280
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
15
0.280
Why?
Aged
15
2011
9741
0.270
Why?
Mitochondria, Liver
1
2007
69
0.270
Why?
Adenoma
1
2008
113
0.270
Why?
Cisplatin
3
2007
286
0.270
Why?
Proteoglycans
2
2003
83
0.260
Why?
Fibroma
1
2006
37
0.260
Why?
Aged, 80 and over
8
2009
3226
0.240
Why?
Liver
1
2011
1132
0.240
Why?
Membrane Glycoproteins
2
2003
245
0.240
Why?
Survival Analysis
5
2009
661
0.240
Why?
Middle Aged
16
2011
12611
0.240
Why?
Carcinoma, Hepatocellular
1
2007
195
0.230
Why?
Humans
36
2013
50503
0.230
Why?
Prognosis
7
2007
1978
0.230
Why?
DNA Repair Enzymes
1
2004
43
0.230
Why?
Ataxia Telangiectasia
1
2004
6
0.230
Why?
Salivary Ducts
1
2003
3
0.220
Why?
Salivary Gland Neoplasms
1
2003
7
0.220
Why?
Adenocarcinoma, Clear Cell
1
2003
34
0.220
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
68
0.220
Why?
Liver Neoplasms
1
2007
326
0.210
Why?
Obesity
1
2011
1121
0.200
Why?
Adult
14
2011
13577
0.200
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
Why?
Female
22
2012
27081
0.190
Why?
Male
21
2012
25907
0.190
Why?
Epigenesis, Genetic
1
2004
372
0.180
Why?
Transcription Factors
1
2003
565
0.170
Why?
Antineoplastic Agents
2
2010
1172
0.170
Why?
Skin Transplantation
2
2010
43
0.160
Why?
Carrier Proteins
4
2005
298
0.160
Why?
Skin Neoplasms
4
2008
491
0.160
Why?
Tumor Suppressor Proteins
2
2011
128
0.150
Why?
Loss of Heterozygosity
2
2008
75
0.150
Why?
DNA Damage
2
2011
301
0.140
Why?
Survival Rate
3
2009
909
0.140
Why?
Neoplasm Invasiveness
4
2007
269
0.130
Why?
Graft Survival
3
2011
159
0.120
Why?
Ki-67 Antigen
2
2011
56
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
572
0.120
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
32
0.120
Why?
Algorithms
2
2008
625
0.110
Why?
Immunoenzyme Techniques
4
2013
137
0.110
Why?
Cadherins
2
2005
63
0.110
Why?
Prostatic Neoplasms
2
2008
384
0.110
Why?
Thyroid Neoplasms
2
2007
112
0.110
Why?
Keratosis
2
2003
14
0.110
Why?
Receptors, Cell Surface
1
2013
116
0.100
Why?
Base Sequence
2
2004
639
0.100
Why?
Wound Healing
2
2010
186
0.100
Why?
Carcinoma in Situ
2
2003
73
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Laryngectomy
3
2007
27
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.100
Why?
Aminolevulinic Acid
1
2011
8
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Lasers, Dye
1
2011
10
0.100
Why?
Arteriovenous Malformations
1
2013
76
0.100
Why?
Antigens, CD
1
2013
222
0.100
Why?
Cell Line, Tumor
4
2010
1398
0.100
Why?
Photosensitizing Agents
1
2011
19
0.100
Why?
Propranolol
1
2012
79
0.090
Why?
Lymphatic Abnormalities
1
2011
22
0.090
Why?
Microtubule-Associated Proteins
1
2011
66
0.090
Why?
Photochemotherapy
1
2011
33
0.090
Why?
Biopsy
3
2011
588
0.090
Why?
Homeodomain Proteins
1
2011
79
0.090
Why?
Laser Therapy
1
2011
83
0.090
Why?
Taxoids
1
2010
37
0.090
Why?
Drug Resistance, Multiple
1
2010
24
0.090
Why?
Hemangioma
1
2012
83
0.090
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
57
0.090
Why?
Gene Deletion
1
2011
261
0.080
Why?
Follow-Up Studies
4
2011
2242
0.080
Why?
Neoplasm Staging
3
2007
746
0.080
Why?
Gene Expression Regulation, Neoplastic
4
2010
833
0.080
Why?
Mice, Transgenic
1
2011
540
0.080
Why?
Disease Models, Animal
2
2011
1436
0.080
Why?
Animals
8
2011
13124
0.080
Why?
Paraffin Embedding
1
2008
51
0.080
Why?
Sulfites
1
2008
1
0.080
Why?
Drug Resistance, Neoplasm
1
2010
316
0.080
Why?
Microsatellite Repeats
1
2008
37
0.080
Why?
Mice
4
2011
5687
0.080
Why?
Blood Glucose
1
2011
446
0.080
Why?
Neoplasm Seeding
1
2008
4
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1000
0.070
Why?
Chordoma
1
2008
8
0.070
Why?
Skull Base Neoplasms
1
2008
20
0.070
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.070
Why?
Laryngeal Nerves
1
2007
15
0.070
Why?
Apoptosis Regulatory Proteins
2
2005
82
0.070
Why?
Receptors, Thyrotropin
1
2007
8
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
59
0.070
Why?
Methylation
2
2007
118
0.070
Why?
Symporters
1
2007
17
0.070
Why?
Pattern Recognition, Automated
1
2007
40
0.070
Why?
Cell Proliferation
1
2011
985
0.070
Why?
Image Enhancement
1
2007
54
0.070
Why?
Precancerous Conditions
1
2008
82
0.070
Why?
Risk Factors
3
2008
3724
0.070
Why?
Prostate
1
2008
114
0.070
Why?
Carcinoma, Papillary
1
2007
47
0.070
Why?
Transgenes
1
2007
52
0.070
Why?
MicroRNAs
1
2010
344
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
105
0.070
Why?
Neoplasm Recurrence, Local
2
2008
629
0.070
Why?
Child
5
2012
6906
0.070
Why?
Cell Nucleus
1
2007
182
0.070
Why?
Child, Preschool
3
2012
3942
0.070
Why?
Syndecans
2
2003
37
0.070
Why?
RNA, Messenger
2
2007
1089
0.070
Why?
Protein Transport
1
2007
181
0.070
Why?
Syndecan-1
2
2003
75
0.070
Why?
Genomics
1
2008
279
0.070
Why?
Artificial Intelligence
1
2007
96
0.060
Why?
Adenomatous Polyposis Coli Protein
1
2005
2
0.060
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
25
0.060
Why?
Ear, Inner
1
2005
18
0.060
Why?
Melanoma
1
2008
280
0.060
Why?
Guanine
1
2004
40
0.060
Why?
Cell Physiological Phenomena
1
2004
3
0.060
Why?
Cell Cycle Proteins
1
2005
161
0.060
Why?
Cytochromes c
1
2003
28
0.060
Why?
DNA Adducts
1
2004
79
0.060
Why?
Salivary Proteins and Peptides
1
2003
8
0.050
Why?
Statistics as Topic
1
2003
88
0.050
Why?
Isoenzymes
1
2003
168
0.050
Why?
Base Pair Mismatch
1
2003
22
0.050
Why?
Adenocarcinoma, Follicular
1
2003
3
0.050
Why?
Adenocarcinoma, Papillary
1
2003
5
0.050
Why?
Tunica Intima
1
2003
55
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
150
0.050
Why?
Retrospective Studies
4
2007
6263
0.050
Why?
DNA-Binding Proteins
1
2005
418
0.050
Why?
Keratoacanthoma
1
2002
7
0.050
Why?
Collagen
1
2003
204
0.050
Why?
Renal Dialysis
1
2003
171
0.050
Why?
Platelet Aggregation Inhibitors
1
2003
174
0.050
Why?
Alcohol Drinking
1
2003
227
0.050
Why?
Combined Modality Therapy
4
2004
641
0.050
Why?
Molecular Sequence Data
1
2003
778
0.050
Why?
Lung
1
2005
504
0.050
Why?
Blotting, Western
2
2013
578
0.050
Why?
Adolescent
2
2012
6443
0.050
Why?
Cohort Studies
1
2005
1452
0.050
Why?
Blood Platelets
1
2003
251
0.040
Why?
Prevalence
1
2004
971
0.040
Why?
Tomography, X-Ray Computed
1
2006
1164
0.040
Why?
Smoking
1
2003
507
0.040
Why?
Random Allocation
2
2010
289
0.040
Why?
Quality of Life
1
2004
851
0.040
Why?
Electrophoresis, Agar Gel
2
2008
11
0.030
Why?
Sensitivity and Specificity
2
2010
859
0.030
Why?
Hyperplasia
2
2008
96
0.030
Why?
Neck Dissection
2
2008
30
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1372
0.030
Why?
Fluorouracil
2
2004
58
0.030
Why?
Photosensitivity Disorders
2
2003
9
0.030
Why?
Cross-Sectional Studies
2
2012
1610
0.030
Why?
Infant
2
2012
3628
0.030
Why?
Lymph Node Excision
2
2004
131
0.030
Why?
Head
1
2013
70
0.030
Why?
Actins
1
2013
114
0.030
Why?
Neck
1
2013
99
0.020
Why?
Treatment Outcome
3
2011
5283
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Antigens, Nuclear
1
2011
23
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
45
0.020
Why?
Tissue Culture Techniques
1
2011
37
0.020
Why?
Administration, Topical
1
2011
57
0.020
Why?
Transplantation, Heterologous
1
2011
75
0.020
Why?
Time Factors
2
2010
2935
0.020
Why?
Mice, Nude
1
2011
248
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Rats
2
2009
3292
0.020
Why?
Pharmacogenetics
1
2010
50
0.020
Why?
Granulation Tissue
1
2010
9
0.020
Why?
Tissue and Organ Harvesting
1
2010
23
0.020
Why?
Myeloid Cells
1
2010
37
0.020
Why?
Probability
1
2010
164
0.020
Why?
Endothelial Cells
1
2011
258
0.020
Why?
Carcinoma
1
2010
137
0.020
Why?
Pilot Projects
1
2011
698
0.020
Why?
Graft Rejection
1
2010
172
0.020
Why?
Neovascularization, Physiologic
1
2009
68
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Chi-Square Distribution
1
2009
277
0.020
Why?
Centromere
1
2008
13
0.020
Why?
Microdissection
1
2008
18
0.020
Why?
Cell Line, Transformed
1
2008
73
0.020
Why?
Telomere
1
2008
35
0.020
Why?
Melanocytes
1
2008
38
0.020
Why?
Gene Dosage
1
2008
74
0.020
Why?
Fluorescent Dyes
1
2008
103
0.020
Why?
Iodine
1
2007
9
0.020
Why?
Genetic Markers
1
2008
104
0.020
Why?
Mice, Knockout
1
2010
844
0.020
Why?
Predictive Value of Tests
1
2010
930
0.020
Why?
Fatal Outcome
1
2008
197
0.020
Why?
Cluster Analysis
1
2007
219
0.020
Why?
Epithelial Cells
1
2008
207
0.020
Why?
Prospective Studies
1
2011
2378
0.020
Why?
Buffers
1
2005
9
0.020
Why?
Round Window, Ear
1
2005
6
0.020
Why?
Rats, Inbred Lew
1
2005
49
0.020
Why?
Injections
1
2005
57
0.020
Why?
Phosphates
1
2005
46
0.020
Why?
Rats, Sprague-Dawley
1
2009
1585
0.020
Why?
Sodium Chloride
1
2005
55
0.010
Why?
Protein Isoforms
1
2005
116
0.010
Why?
Mice, Inbred C57BL
1
2010
1808
0.010
Why?
Drug Combinations
1
2005
127
0.010
Why?
Antibodies
1
2005
153
0.010
Why?
Statistics, Nonparametric
1
2004
192
0.010
Why?
Reproducibility of Results
1
2007
1197
0.010
Why?
Disease-Free Survival
1
2005
444
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Elastin
1
2003
22
0.010
Why?
Polytetrafluoroethylene
1
2003
32
0.010
Why?
Up-Regulation
1
2005
446
0.010
Why?
DNA Primers
1
2003
206
0.010
Why?
Radiotherapy
1
2004
125
0.010
Why?
Anastomosis, Surgical
1
2003
66
0.010
Why?
Dogs
1
2003
186
0.010
Why?
Vascular Patency
1
2003
83
0.010
Why?
Radiotherapy, Adjuvant
1
2003
64
0.010
Why?
Myocytes, Smooth Muscle
1
2003
87
0.010
Why?
Chemotherapy, Adjuvant
1
2003
121
0.010
Why?
Extracellular Matrix
1
2003
109
0.010
Why?
Graft Occlusion, Vascular
1
2003
74
0.010
Why?
Thyroidectomy
1
2003
60
0.010
Why?
Biopsy, Needle
1
2003
178
0.010
Why?
Young Adult
1
2012
4102
0.010
Why?
Lymphatic Metastasis
1
2003
222
0.010
Why?
Stromal Cells
1
2002
75
0.010
Why?
Models, Biological
1
2003
716
0.010
Why?
Risk Assessment
1
2003
1270
0.010
Why?
Arkansas
1
2004
1985
0.010
Why?
Diagnosis, Differential
1
2002
1033
0.010
Why?
Pregnancy
1
2003
2452
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description